China Suzhou-based Bingjing Intelligent Medical (\u82cf\u5dde\u51b0\u6676\u667a\u80fd\u533b\u7597\u79d1\u6280\u6709\u9650\u516c\u53f8) closes tens of millions of yuan Series PreA Financing led by Dalton Venture (\u9053\u5f64\u6295\u8d44) and followed by SND Financial Holdings (\u82cf\u9ad8\u65b0\u91d1\u63a7) and Marathon Venture Partners (\u8fdc\u6bc5\u8d44\u672c), for the development, clinical trials, and marketing of the next generation of high-definition and high-speed Intracardiac Echocardiography (ICE) ultrasound products.<\/p>\n\n\n\n
Founded in October 2021, Bingjing Intelligent Medical focuses on cardiovascular interventional imaging, designing, developing, and producing dedicated digital interventional imaging products for cardiac and vascular diseases.<\/p>\n\n\n\n
The company’s founder, Zhang Jihong (\u5f20\u5409\u5b8f), who worked at the global headquarters of GE Healthcare, has over 10 years of experience in the medical device industry, from upstream product development to downstream marketing and sales.<\/p>\n\n\n\n
The core team members are senior experts from leading medical device companies such as GE Healthcare, Philips, Siemens Healthineers, Johnson & Johnson MedTech and Abbott.<\/p>\n\n\n\n
The company has invested significant funds and manpower in the research and development of intracardiac ultrasound products, continues to improve the overall performance of the products, and will build the first ICE automated batch production line in China. <\/p>\n\n\n\n
The Company has established an R&D and process manufacturing centre of several thousand square metres, equipped with the world’s most advanced precision R&D equipment, the only acoustic simulation testing equipment in China, and the only automated production and testing system in China.<\/p>","protected":false},"excerpt":{"rendered":"
for the development, clinical trials, and marketing of the next generation of high-definition and high-speed intracardiac ultrasound products<\/p>","protected":false},"author":2,"featured_media":23085,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[5,488,10],"tags":[453,594],"class_list":["post-17543","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asia-pacific","category-breaking-news","category-strategic-development","tag-china","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/17543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/comments?post=17543"}],"version-history":[{"count":7,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/17543\/revisions"}],"predecessor-version":[{"id":17555,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/17543\/revisions\/17555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/media\/23085"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/media?parent=17543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/categories?post=17543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/tags?post=17543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}